Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2018, 6(2), 26-29
DOI: 10.12691/AJMCR-6-2-4
Case Report

Invasive Ductal Carcinoma of the Breast with Medullary Features or Medullary Carcinoma of the Breast: A Challenging Histopathological Case Report with Review of Literature

Mazaher Ramezani1, Shima Jalalvandi1, Fatemeh Rezaali1 and Masoud Sadeghi2,

1Molecular Pathology Research Center, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

Pub. Date: March 30, 2018

Cite this paper

Mazaher Ramezani, Shima Jalalvandi, Fatemeh Rezaali and Masoud Sadeghi. Invasive Ductal Carcinoma of the Breast with Medullary Features or Medullary Carcinoma of the Breast: A Challenging Histopathological Case Report with Review of Literature. American Journal of Medical Case Reports. 2018; 6(2):26-29. doi: 10.12691/AJMCR-6-2-4

Abstract

Medullary Breast carcinoma (MBC) is an infrequent type of breast cancer and is in the differential diagnosis of invasive ductal carcinoma (IDC) with medullary features. We reported a 35-year-old lady with left breast since 6 months ago. CEA tumor marker serum level and CA15-3 were within normal limits. The patient underwent the incomplete left mastectomy. Gross specimen revealed gray-yellow hemorrhagic tumor lesion with pushing border. Histopathology demonstrated highly atypical cells with lymphocytic infiltration and mainly pushing border but with infiltrative margin in few areas. The permanent diagnosis was “invasive ductal carcinoma with medullary features“. We conclude that careful histopathological evaluation and considering strict criteria is necessary for definitive diagnosis and subsequent proper treatment.

Keywords

invasive ductal carcinoma, medullary carcinoma, breast cancer, case report

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Aouni NE, Athanasiou A, Mansouri D, Marsiglia H, Mathieu MC, Suciu V, Vielh P. Medullary breast carcinoma: a case report with cytological features and histological confirmation. Diagn Cytopathol. 2006;34(10):701-3.
 
[2]  Flucke U, Flucke MT, Hoy L, Breuer E, Goebbels R, Rhiem K, et al Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology. 2010; 56(7): 852-9.
 
[3]  Racz MM1, Pommier RF, Troxell ML. Fine-needle aspiration cytology of medullary breast carcinoma: report of two cases and review of the literature with emphasis on differential diagnosis. Diagn Cytopathol. 2007; 35(6): 313-8.
 
[4]  Kleer CG. Carcinoma of the Breast With Medullary-like Features: Diagnostic Challenges and Relationship With BRCA1 and EZH2 Functions. Arch Pathol Lab Med. 2009; 133(11): 1822-5.
 
[5]  Kleer CG, Michael CW. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate. Diagn Cytopathol. 2000; 23(1): 39-42.
 
[6]  Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 1977; 40(4): 1365-85.
 
[7]  McCarty Matthew J, Vukelja Svetislava J. Atypical medullary carcinoma of the breast metastatic to the oral cavity. American Journal of Otolaryngology.1994; 15(4): 289-91.
 
[8]  Sobrino-Mota V, Lagarejos-Bernardo S, Varela-Mezquita B, Castro Y, Segura-González C, Pérez-Milán F. Unusual sonographic findings in a case of atypical medullary inflammatory carcinoma of the breast. J Clin Ultrasound. 2008; 36(3): 166-8.
 
[9]  Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006; 19(2): 264-71.
 
[10]  Galzerano A, Rocco N, Accurso A, Ciancia G, Campanile AC, Caccavello F, et al. Medullary breast carcinoma in an 18-year-old female: report on one case diagnosed on fine-needle cytology sample. Diagn Cytopathol. 2014; 42(5): 445-8.
 
[11]  Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adélaïde J, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006; 66(9): 4636-44.